National Healthcare (NHC) EBITDA (2010 - 2026)

National Healthcare has reported EBITDA for 17 years, with the latest figure at $32.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 4.83% year-over-year to $32.3 million; the trailing twelve-month figure through Mar 2026 stood at $129.8 million (up 23.67% YoY), and the FY2025 full-year result was $128.4 million, up 42.78% from the prior year.
• EBITDA for Q1 2026 stood at $32.3 million, down from $33.1 million in the prior quarter.
• The five-year high for EBITDA was $34.1 million in Q2 2025, with the low at -$17.1 million in Q4 2022.
• Historically, EBITDA has averaged $18.5 million across 5 years, with a median of $20.4 million in 2023.
• Annual changes were most pronounced in 2022 — EBITDA slumped 68.05% — and 2023, when it soared 219.4%.
• National Healthcare's EBITDA stood at -$17.1 million in 2022, then jumped by 219.37% to $20.4 million in 2023, then jumped by 41.42% to $28.9 million in 2024, then increased by 14.55% to $33.1 million in 2025, then dropped by 2.61% to $32.3 million in 2026.
• The last three EBITDA figures came in at $32.3 million (Q1 2026), $33.1 million (Q4 2025), and $30.4 million (Q3 2025), per Business Quant data.